Found: 4
Select item for more details and to access through your institution.
Post-exposure vaccine effectiveness and contact management in the mpox outbreak, Madrid, Spain, May to August 2022.
- Published in:
- Eurosurveillance (15607917), 2023, v. 28, n. 24, p. 25, doi. 10.2807/1560-7917.ES.2023.28.24.2200883
- By:
- Publication type:
- Article
Authors' response: Bias in the vaccine effectiveness estimates of one-dose post-exposure prophylaxis against mpox.
- Published in:
- Eurosurveillance (15607917), 2023, v. 28, n. 34, p. 30, doi. 10.2807/1560-7917.ES.2023.28.34.2300442
- By:
- Publication type:
- Article
Effectiveness of Modified Vaccinia Ankara-Bavaria Nordic Vaccination in a Population at High Risk of Mpox: A Spanish Cohort Study.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 2, p. 476, doi. 10.1093/cid/ciad645
- By:
- Publication type:
- Article
The effectiveness of nirsevimab in reducing the burden of disease due to respiratory syncytial virus (RSV) infection over time in the Madrid region (Spain): a prospective population-based cohort study.
- Published in:
- Frontiers in Public Health, 2024, p. 01, doi. 10.3389/fpubh.2024.1441786
- By:
- Publication type:
- Article